Condensed Consolidated Statements of Earnings (unaudited) - USD ($) shares in Millions, $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Income Statement [Abstract]
Net Sales	$ 1,988.6	$ 2,007.6	$ 3,964.1	$ 4,025.2
Type of Revenue [Extensible List]	us-gaap:ProductMember	us-gaap:ProductMember	us-gaap:ProductMember	us-gaap:ProductMember
Cost of products sold, excluding intangible asset amortization	$ 581.3	$ 583.7	$ 1,134.7	$ 1,159.5
Type of Cost, Good or Service [Extensible List]	us-gaap:ProductMember	us-gaap:ProductMember	us-gaap:ProductMember	us-gaap:ProductMember
Intangible asset amortization	$ 146.9	$ 149.5	$ 290.3	$ 300.3
Research and development	112.1	99.1	213.8	194.8
Selling, general and administrative	840.3	791.3	1,636.7	1,593.0
Intangible asset impairment	70.1		70.1
Acquisition, integration and related	10.5	50.5	21.2	96.5
Quality remediation	22.7	37.5	42.4	80.1
Operating expenses	1,783.9	1,711.6	3,409.2	3,424.2
Operating Profit	204.7	296.0	554.9	601.0
Other expense, net	(4.7)	(2.9)	(5.2)	(6.5)
Interest expense, net	(59.7)	(75.3)	(117.7)	(153.3)
Earnings before income taxes	140.3	217.8	432.0	441.2
Provision for income taxes	8.4	32.9	53.9	80.1
Net Earnings	131.9	184.9	378.1	361.1
Less: Net (loss) earnings attributable to noncontrolling interest	(1.8)	(0.1)	(1.7)	1.4
Net Earnings of Zimmer Biomet Holdings, Inc.	$ 133.7	$ 185.0	$ 379.8	$ 359.7
Earnings Per Common Share
Basic	$ 0.65	$ 0.91	$ 1.86	$ 1.77
Diluted	$ 0.65	$ 0.90	$ 1.84	$ 1.76
Weighted Average Common Shares Outstanding
Basic	204.8	203.3	204.6	203.2
Diluted	206.2	204.6	206.0	204.6